Hepion Pharmaceuticals
Why Robinhood?
You can watch HEPA and buy or sell other stocks, ETFs, and their options commission-free!About HEPA
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease.
HEPA Key Statistics
Stock Snapshot
Hepion Pharmaceuticals(HEPA) stock is priced at $0.83, giving the company a market capitalization of 63.19M. It carries a P/E multiple of -0.90.
During the trading day, Hepion Pharmaceuticals(HEPA) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Hepion Pharmaceuticals(HEPA) stock has reached 0, versus its average volume of 325.66K.
The stock's 52-week range extends from a low of $0.26 to a high of $1.19.
The stock's 52-week range extends from a low of $0.26 to a high of $1.19.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.